User
0
Your Cart Item

₹ 0.00

0 Test(s)

Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining a report for the AML/ETO t(8;21) Test By FISH is 7 days.

What are the prerequisites for the test AML/ETO t(8;21) Test By FISH

  • Specimen: Bone marrow aspirate or peripheral blood
  • Requisition form: Properly filled out with patient information
  • Consent form: Signed by the patient or legal guardian
  • Test request: Ordered by a licensed healthcare provider
  • Proper sample collection: Collected by a trained phlebotomist or healthcare provider
  • Transportation: Sample should be transported to the lab in a timely manner
  • Storage: Sample should be stored according to lab guidelines

What are the measure values for the test AML/ETO t(8;21) Test By FISH

  • Positive: Presence of AML/ETO fusion gene
  • Negative: Absence of AML/ETO fusion gene
  • Indeterminate: Inconclusive result, further testing may be needed

What does this test AML/ETO t(8;21) Test By FISH identify?

This test identifies the presence of the AML/ETO t(8;21) translocation in individuals with acute myeloid leukemia (AML). This translocation involves a fusion of the AML1 gene on chromosome 21 with the ETO gene on chromosome 8, resulting in a chimeric gene known as AML1-ETO. This genetic abnormality is associated with a specific subtype of AML and can help guide treatment decisions and predict prognosis for patients.

Why is this test AML/ETO t(8;21) Test By FISH taken?

AML/ETO t(8;21) Test By FISH

Why is this test taken?

The AML/ETO t(8;21) test by FISH is taken to detect the presence of a specific chromosomal abnormality in a person's bone marrow cells. This abnormality, known as the t(8;21) translocation, is commonly found in patients with acute myeloid leukemia (AML).

By identifying this translocation, healthcare providers can make a more accurate diagnosis of AML and determine the appropriate treatment plan for the patient. This test is particularly useful in distinguishing AML with t(8;21) from other types of leukemia that may have similar symptoms but require different treatment approaches.

Overall, the AML/ETO t(8;21) test by FISH plays a crucial role in the diagnosis and management of AML, helping healthcare providers tailor treatment strategies to individual patients based on their specific genetic abnormalities.

Popular FAQs on Test

The AML/ETO t(8;21) Test By FISH is a laboratory test that uses fluorescence in situ hybridization (FISH) to detect a specific genetic abnormality known as the t(8;21) translocation. This translocation is commonly found in patients with acute myeloid leukemia (AML) and is associated with a more favorable prognosis.
During the test, a sample of the patient's bone marrow or blood cells is collected and treated with special fluorescent probes that specifically bind to the AML/ETO fusion gene created by the t(8;21) translocation. The cells are then examined under a fluorescence microscope to see if the fusion gene is present.
A positive result on the test indicates that the AML/ETO fusion gene created by the t(8;21) translocation is present in the patient's cells. This genetic abnormality is commonly associated with a specific subtype of AML known as AML with t(8;21), which has a more favorable prognosis compared to other subtypes of AML.
A negative result on the test indicates that the AML/ETO fusion gene is not present in the patient's cells. This may suggest that the patient's AML is not associated with the t(8;21) translocation and may have a different genetic profile and prognosis.
The AML/ETO t(8;21) Test By FISH is not a definitive diagnostic test for AML on its own. It is typically used in conjunction with other laboratory tests, such as cytogenetic analysis and molecular testing, to help confirm a diagnosis of AML and provide additional prognostic information.

Customer Google Rating

2 week ago

Being the sole breadwinner, I was worried about my aging parents. UHL health plan provided the ideal coverage with additional benefits like fastest claim settlement .

Rahul Kashyap People

2 week ago

Choosing UHL HEALTH PLANS felt like an adventure. The website guided me smoothly and I was thrilled with the ease of comparison. Cheers UHL. The website guided me smoothly

Adarsh Kumar People

4 weeks ago

Having UHL heath plan which is so beneficial and the investment is also low. Service provided is quick and on time. Online renewals are made so simple through online portal service.

Kushagra People

2 week ago

I got the UHL Health Plan at a low cost, and the coverage is as high as promised. The service is excellent, and their staff is available 24/7 to assist with any inquiries.

Mahima Pandey People

2 week ago

I’m securing my future by investing in the UHL Health Plan and opting for their retirement health plans. In my opinion, it’s the best investment, as the policy covers 92% of my healthcare needs.

Ajeet People

1 week ago

The claims process is easy due to the fast service provided by their dedicated staff. Plus, it offers tax-saving benefits, which is another great advantage. I'm very satisfied with it.

Chitransh Trivedi People

1 week ago

I purchased the UHL Health Plan, opting for their term health coverage. The premiums are affordable, around Rs. 10K per year, making it a great option for my budget.

Tushar People

2 week ago

I have the UHL Health Plan for my family of four, and it has proven to be reliable with many benefits and great returns on investment. The policy coverage is around 90%.

Naina Verma People

2 week ago

I’m securing my future by investing in the UHL Health Plan and opting for their retirement health plans. In my opinion, it’s the best investment, as the policy covers 92% of my healthcare needs.

Anil People